SCHEMBL410993

SCHEMBL410993

CN1C2CCCC1CCC2

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 1/20 0.57
CYP2C9 P11712 2/20 0.43
LMNA P02545 1/20 0.43
CHRM4 P08173 4/20 0.35
CHRM2 P08172 3/20 0.35
CHRM1 P11229 3/20 0.35
CHRM3 P20309 3/20 0.35
CHRNB4 P30926 2/20 0.35
CHRNA3 P32297 2/20 0.35
HTR3E A5X5Y0 1/20 0.35
HTR3B O95264 1/20 0.35
CHRM5 P08912 1/20 0.35
CHRNB2 P17787 1/20 0.35
HRH1 P35367 1/20 0.35
CHRNA7 P36544 1/20 0.35
CHRNA4 P43681 1/20 0.35
HTR3A P46098 1/20 0.35
TMEM97 Q5BJF2 1/20 0.35
HTR3D Q70Z44 1/20 0.35
HTR3C Q8WXA8 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14320158 1.00 MAPK1 (0.57) MAPK1CYP2C9LMNACHRM4CHRM2
SCHEMBL22311884 0.96
SCHEMBL278483 0.96 MAPK1 (0.55) MAPK1CYP2C9LMNACHRM4CHRM2
SCHEMBL44881 0.96
SCHEMBL12955575 0.96
SCHEMBL14434380 0.96
SCHEMBL44882 0.96
SCHEMBL24901096 0.93 MAPK1 (0.52) MAPK1CYP2C9LMNACHRM4CHRM2
Hydrochloric Acid SCHEMBL16245107 0.93 MAPK1 (0.52) MAPK1CYP2C9LMNACHRM4CHRM2
SCHEMBL22421153 0.93 MAPK1 (0.52) MAPK1CYP2C9LMNACHRM4CHRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 152 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3286163-A1 METHOD FOR PREPARING STRUCTURED DIRECTING AGENT Johnson Matthey Public Limited Company (GB) 2018-02-28 EP claimed
WO-2016172128-A1 METHOD FOR PREPARING STRUCTURED DIRECTING AGENT JOHNSON MATTHEY PUBLIC LIMITED COMPANY (GB) 2016-10-27 WO claimed
US-9371347-B2 dppf-like compounds and method of manufacture and use BROWN UNIVERSITY (US) 2016-06-21 US claimed
US-20160002274-A1 dppf-LIKE COMPOUNDS AND METHOD FO MANUFACTURE AND USE NATIONAL SCIENCE FOUNDATION 2016-01-07 US claimed
US-20150158020-A1 SYNTHESIS OF ZEOLITES USING AN ORGANOAMMONIUM COMPOUND UOP LLC 2015-06-11 US claimed
WO-2014130410-A1 DPPF-LIKE COMPOUNDS AND METHODS BROWN UNIVERSITY (US) 2014-08-28 WO claimed
US-8124600-B2 5-HT3 receptor modulators, methods of making, and use thereof ALBANY MOLECULAR RESEARCH, INC. (US) 2012-02-28 US claimed
EP-2310019-A2 5-HT3 RECEPTOR MODULATORS, METHODS OF MAKING, AND USE THEREOF Albany Molecular Research, Inc. (US) 2011-04-20 EP claimed
WO-2009155054-A2 5-HT3 RECEPTOR MODULATORS, METHODS OF MAKING, AND USE THEREOF ALBANY MOLECULAR RESEARCH, INC. (US) 2009-12-23 WO claimed
US-20090298809-A1 5-HT3 RECEPTOR MODULATORS, METHODS OF MAKING, AND USE THEREOF ALBANY MOLECULAR RESEARCH, INC. (US) 2009-12-03 US claimed
US-12480131-B2 Tropane alkaloid (TA) producing non-plant host cells, and methods of making and using the same THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) 2025-11-25 US disclosed
US-12391848-B2 Polishing composition, method for producing polishing composition, polishing method, and method for producing semiconductor substrate FUJIMI INCORPORATED (JP) 2025-08-19 US disclosed
CN-113784758-B Non-plant host cells producing tropane alkaloids (TA) and methods of making and using the same 小利兰·斯坦福大学托管委员会 2025-03-07 CN disclosed
US-20250075147-A1 FRAGRANCE AND FLAVOR COMPOSITIONS COMPRISING NEW FLAVOR AND FRAGRANCE INGREDIENTS OSMO LABS, PBC 2025-03-06 US disclosed
CN-113388328-B Polishing composition, method for producing polishing composition, polishing method, and method for producing semiconductor substrate 福吉米株式会社 2024-10-25 CN disclosed
EP-0618880-A1 A PROCESS FOR PREPARING MOLECULAR SIEVES USING 9-AZABICYCLO[3.3.1]NONANE TEMPLATES CHEVRON RESEARCH AND TECHNOLOGY COMPANY, (US) 1994-10-12 EP disclosed
WO-1994008900-A1 A PROCESS FOR PREPARING MOLECULAR SIEVES USING 9-AZABICYCLO[3.3.1]NONANE TEMPLATES CHEVRON RESEARCH AND TECHNOLOGY COMPANY, A DIVISION OF CHEVRON U.S.A. INC. (US) 1994-04-28 WO disclosed
US-5273736-A Process for preparing molecular sieves using 9-azabicyclo [3.3.1] nonane templates CHEVRON RESEARCH AND TECHNOLOGY COMPANY (US) 1993-12-28 US disclosed
US-5202333-A Tricyclic 5-HT3 receptor antagonists SYNTEX (U.S.A.) INC. (US) 1993-04-13 US disclosed
US-4370323-A 2-Cyanoaziridinyl-(1)-2-substituted-aziridinyl-(1)-methanes BOEHRINGER MANNHEIM GMBH (DE) 1983-01-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090298809-A1 5-HT3 RECEPTOR MODULATORS, METHODS OF MAKING, AND USE THEREOF HTR3A, HTR5A, HTR3B MAPK1 3092/4885CYP2C9 472/4885LMNA 4803/4885
US-20160002274-A1 dppf-LIKE COMPOUNDS AND METHOD FO MANUFACTURE AND USE DBF4, CD22, CD2BP2 MAPK1 3874/4885CYP2C9 1054/4885LMNA 4193/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.